Skip to main content
. 2020 Jul;12(7):3478–3487. doi: 10.21037/jtd-20-1557A

Figure 3.

Figure 3

The FRAT2 expression results of the clinical data analysis from TCGA. (A) The expression levels and copy number variation were positively correlated (P=9.126×10−23). (B) FRAT2 overexpression resulted in a shorter overall survival time and poor prognosis (P=0.049). FRAT2, frequently rearranged in advanced T-cell lymphomas 2; TCGA, the Cancer Genome Atlas.